Jadwiga Fabijańska-Mitek

Jadwiga Fabijańska-Mitek

Auto-generated profile, based on publicly available information

Jadwiga Fabijańska-Mitek

Zakład Immunohematologii, Centrum Medyczne Kształcenia Podyplomowego, Warszawa, Polska

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2016 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
AGA. Gielezynska
A. Gielezynska
ASAnna Stachurska-Skrodzka
Anna Stachurska-Skrodzka
JFJ. Fabijanska‐Mitek
J. Fabijanska‐Mitek
MDMarzena Dębska
Marzena Dębska
KMK. Muzyka
K. Muzyka
EKE. Kraszewska
E. Kraszewska

1 September 2001 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
EZEwa Zdebska
Ewa Zdebska
EGEwa Gołaszewska
Ewa Gołaszewska
JFJadwiga Fabijańska‐Mitek
Jadwiga Fabijańska‐Mitek
HSHarry Schachter
Harry Schachter
HSHannah Shalev
Hannah Shalev
JKJerzy Kościelak
Jerzy Kościelak
Congenital dyserythropoietic anaemia type II (CDA II) is well known for glycosylation abnormalities affecting erythrocyte membrane glycoconjugates that encompass hypoglycosylation of band 3 glycoprotein and accumulation of glycosphingolipids: lactotriaosylceramides, neolactotriaosylceramide and polyglycosylceramides. These abnormalities were not observed in erythrocytes from patients with CDA of either type I or III. Recently, however, we have described a CDA type I patient in Poland with identical, though less pronounced, glycoconjugate abnormalities to those observed in patients with CDA type II. The abnormalities included partial unglycosylation of O‐linked glycosylation sites in glycophorin A. These abnormalities are now reported in three Bedouin patients from Israel with CDA type I. In addition, the erythrocyte membranes of these patients exhibited highly increased globotetraosylceramide content. Glycoconjugate abnormalities were also present in erythrocyte membranes from three patients from Northern Sweden with CDA type III but they almost exclusively affected glycosphingolipids. In erythrocytes of all patients examined including one with CDA type II, polyglycosylceramides were significantly hypoglycosylated although, on a molar basis, their contents in erythrocyte membranes were increased. Thus, glycoconjugate abnormalities of varying intensity occur in erythrocyte membranes from all patients with CDA that were investigated.

16 May 2006 in Clinical and Laboratory Haematology
Verified
Journal Article
Closed access
PDF file
JFJ. Fabijan´sKa-Mitek
J. Fabijan´sKa-Mitek
RPR. Pogło´d
R. Pogło´d
AAA. Adamowicz-Salach
A. Adamowicz-Salach
HŁH. Łopieńska
H. Łopieńska

8 July 2019 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
ASAnna Stachurska-Skrodzka
Anna Stachurska-Skrodzka
MDMałgorzata Dorman
Małgorzata Dorman
JKJolanta Korsak
Jolanta Korsak
DGDamian Gawel
Damian Gawel
MGMałgorzata Grzanka
Małgorzata Grzanka
JFJadwiga Fabijanska‐Mitek
Jadwiga Fabijanska‐Mitek

30 September 2017 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
ALA. Loniewska‐Lwowska
A. Loniewska‐Lwowska
KKK. Koza
K. Koza
EME. Mendek‐Czajkowska
E. Mendek‐Czajkowska
PWP. Wieszczy
P. Wieszczy
AAA. Adamowicz‐Salach
A. Adamowicz‐Salach
JFJ. Fabijanska‐Mitek
J. Fabijanska‐Mitek

1 May 1999 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
BŻB. Żupańska
B. Żupańska
IBI. Bogdanik
I. Bogdanik
JFJ. Fabijanska‐Mitek
J. Fabijanska‐Mitek
HPH. Pyl
H. Pyl